India seen struggling to fulfil sugar export quota, industry sources say
DUBAI, Feb 12 (Reuters) - India has exported up to 500,000 metric tons of sugar so far this season, but the pace is already slowing, and it may struggle to fulfil the one million tons allowed by the government, trade and industry sources said on Wednesday.
"There are fears that the one million (ton) quota could actually be reduced," Prakash Naiknavare, managing director of the National Federation of Cooperative Sugar Factories, told Reuters on the sidelines of the annual Dubai Sugar Conference.
India last month allowed exports of 1 million metric tons of sugar during the current season to September 2025 to help mills of the world's second-biggest producer export surplus stocks and prop up local prices.
Naiknavare said exports so far had totalled around 500,000 tons and have mainly focused on neighboring countries Sri Lanka, Bangladesh, and Nepal, as well as Eastern Africa.
Shashikant Pandhare, head of research at Meir India, put exports so far as only 400,000 tons at most and added the pace was slowing down.
He noted mill closures in northern India and struggles elsewhere due to poor harvest conditions.
The closures suggest India will produce less sugar than initially estimated and have lifted local prices, making India less competitive on global export markets.
"I think at most 700,000 tons will be exported by September but I doubt the government will make any changes to the quota," he told Reuters.
Pandhare said there has been a surge in demand from countries with significant Muslim populations, such as Tanzania and Bangladesh, in anticipation of Ramadan, which is set to begin around February 28.
Sanjeev Mishra, the chief executive officer of Tanzania's Kagera Sugar, said, however, that Indian exporters were currently offering at "unrealistic prices" compared to other global sources.
India's decision to allow sugar exports this season was a surprise to some traders with stocks expected to fall this season following crop problems.
Ashwini Srivastava, joint secretary in India's Department of Food and Public Distribution, told the conference that stocks were set to fall to six million tons by the end of this season, down from eight million a year earlier.
Trader and industry sources, however, said the outlook for the 2025/26 cane crop was currently more favourable.
Anup Kumar, managing director of Sucden India told Reuters there was a "very good crop coming" although the size was not yet clear.
He estimated, however, that only around 150,000 tons had been exported so far, mostly to countries around the Indian Ocean.
Get a look at the day ahead in U.S. and global markets with the Morning Bid U.S. newsletter. Sign up here.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
18 minutes ago
- Reuters
VIEW May consumer prices rise moderately
NEW YORK, June 10 (Reuters) - U.S. consumer prices rose slightly in May as gasoline prices remained subdued, but inflation is likely to pick up in the months as tariffs boost the cost of imported goods. The consumer price index CPI increased 0.1% last month after rising 0.2% in April, the Labor Department said on Wednesday. Economists polled by Reuters had forecast the CPI would rise 0.2%. Year on year, the CPI climbed 2.4%, vs a 2.3% rise in the 12 months through April. Excluding the volatile food and energy components, the CPI rose 0.1% after gaining 0.2% in April. The so-called "core" CPI inflation increased 2.8% on a year-on-year basis in May after rising 2.8% in April. Inflation data has been slow to reflect U.S. President Donald Trump's slew of tariffs as retailers are selling merchandise that was built up before the levies took effect. MARKET REACTION: STOCKS: U.S. stock index futures erased earlier gains and were last up 18.5 points, or 0.31%, pointing to a modestly higher open on Wall Street BONDS: The 10-year U.S. Treasury yield fell 3.4 basis points to 4.44% while the two-year yield declined 5.9 basis points to 3.954% FOREX: The dollar index reversed modest gains and was off 0.26% to 98.71 while the euro was up 0.43% at $1.1472 COMMENTS: BRIAN JACOBSEN, CHIEF ECONOMIST, ANNEX WEALTH MANAGEMENT, MENOMONEE FALLS, WISCONSIN: "The post from Trump about the trade deal with China threatened to suck the air out of the importance of this CPI number. A 55% tariff on China does not seem like a good deal for households and businesses in America, but it was slightly better than the 60% tariff platform he campaigned on. "The CPI number was a lot tamer than expected. A lot of imported food items had relatively high inflation, like bananas rising 3.3% in price and toy prices rising 2.2%. Egg deflation is taking place with prices falling 2.7%. A little stability with trade policy could go a long way to help keep inflation from derailing. This is another example of why the Fed may shift its balance of risks to focusing more on growth threats than inflation threats." SLAWOMIR SOROCZYNSKI, HEAD OF FIXED INCOME, CROWN AGENTS INVESTMENT MANAGEMENT, LONDON: 'The CPI printing lower has been a relief. Now we need to clear the 10-year and 30-year Treasury auctions this week and then the market can switch into holiday mode.' GENNADIY GOLDBERG, HEAD OF US RATES STRATEGY, TD SECURITIES, NEW YORK 'The trade policy should still push inflation higher and that really feeds into the market reaction to this CPI print. I would say CPI came in notably better than expected for markets, with both headline and core surprising to the downside. Core goods were softer than expected, especially given weaker apparel prices. Core services were also relatively soft as well, with rents and OER coming in notably lower. 'All in all, this should drive a cautious bull steepening of the (Treasury) yield curve as investors pencil in more cuts. But there's still significant uncertainty around trade and investors know that that should push inflation higher in the months to come. It's a bit of stay of execution for the fixed income market for now.' WASIF LATIF, PRESIDENT AND CHIEF INVESTMENT OFFICER, SARMAYA PARTNERS, PRINCETON, NEW JERSEY 'It came in lower than consensus expected. So it's giving a little bit of a relief rally to the market, between equities rallying and bond yields coming down. But that's the initial reaction but we would see how it comes through over the next few days, weeks and until next month's print. "It's just one print and we have to take that into consideration and with a grain of salt and see how things pan out. There will continue to be impacts from things like tariffs and labor tightness because of immigration crackdown. "The other component is the energy piece. It did contribute a little better than expected numbers, with energy being down. And now this past month, you're seeing energy to hold its own and continue to grind higher so that also needs to be taken in consideration. "But net-net, it's a good number for this week and this month. It provides a little bit of relief. What's interesting is not only are you seeing equities jump here a little bit you're also seeing the US dollar decline because the markets is interpreting that it gives the Fed a little of a runway to reduce rates to the inflationary pressures that aren't there. The thing that is rallying the most on this news is gold.'
Reuters
22 minutes ago
- Reuters
Novo signs $812 million weight-loss drug license deal with US biotech Deep Apple
June 11 (Reuters) - Denmark's Novo Nordisk ( opens new tab is partnering with biotech company Deep Apple Therapeutics in a deal worth up to $812 million to develop drugs for cardiometabolic diseases, including obesity, the California-based company said on Wednesday. Deep Apple discovers drug candidates using its AI-based platform that screens virtual libraries of billions of compounds to cut drug discovery time, the company said. Under the deal, Novo will receive exclusive global rights to develop and commercialize so-called non-incretin oral therapies, which belong to a different class of medicines than its popular weight-loss and diabetes drugs Wegovy and Ozempic. Novo has been trying to strengthen its foothold in the potential $150 billion weight-loss drug market through the development of next-generation treatments as well as acquisitions and partnerships. In March, the company signed two licensing deals and gained access to experimental obesity drugs from Lexicon Pharmaceuticals (LXRX.O), opens new tab and China-based United Laboratories International ( opens new tab. Novo in May ousted CEO Lars Fruergaard Jorgensen over concerns the Danish company - a world leader in the lucrative weight-loss drug market - was losing its first-mover advantage. The company's shares have plunged since hitting a record high in June last year as competition, particularly from U.S. rival Eli Lilly (LLY.N), opens new tab, eats into its market share, while Novo's pipeline of new drugs has failed to impress investors. As part of the license agreement with Novo, Deep Apple will be eligible to receive up to $812 million in payments, as well as potential royalties on sales of any products that emerge from their collaboration.
Reuters
27 minutes ago
- Reuters
Investors pull out of US stocks and into Europe and emerging markets
June 11 (Reuters) - Global investors have moved money from U.S. equities and into European and emerging markets assets, as concerns mount over U.S. fiscal policy, rising debt and the risk that trade tariffs will trigger a recession. Equity mutual funds and exchange-traded funds, or ETFs, domiciled in the United States saw outflows of $24.7 billion in May, the largest in a year, data from LSEG Lipper showed. By contrast, European funds attracted $21 billion in May, lifting year-to-date inflows to $82.5 billion, the highest in four years. Data for 292 emerging market equity ETFs showed inflows of $3.6 billion last month, bringing total inflows this year to $11.1 billion. Analysts said the dollar's weakness and the selloff in U.S. Treasury bonds have eroded the safe-haven appeal of U.S. assets, driving capital into markets with appreciating currencies. European markets have outperformed U.S. peers this year, helped by lower interest rates and optimism over Germany's 1-trillion-euro stimulus plan. The European Central Bank cut interest rates for the eighth time in a year last week in an effort to support the economy, even as it warned of rising trade risks with the United States. Michael Field, chief European market strategist at Morningstar, said the shift from the United States to Europe was initially driven by valuations but increasingly has been fueled by a change in investor sentiment. "With investors rattled by the U.S. administration's actions and worried about the potential drag on equity markets, this may mark the start of a medium-term trend." Since the start of the year, the MSCI United States index (.dMIUS00000PUS), opens new tab has gained 2.7%, while MSCI Europe (.dMIEU00000PUS), opens new tab has risen about 20% and MSCI Asia Pacific (.MIAP00000PUS), opens new tab is up 10%. Emerging market equity funds have also attracted money flows because of improving fundamentals, with Latin America seen as a safe option as trade and military conflicts elsewhere make investors seek more stable regions. Asian economies are increasingly driven by domestic consumption. Manish Raychaudhuri, founder and CEO of Emmer Capital Partners Ltd, said lower debt and stronger growth made Asian equities better positioned to benefit from U.S. capital outflows compared with European ones. "While Italy, France and the UK face rising debt burdens, many Asian economies carry lighter fiscal loads, keeping bond yields stable and investor confidence intact." The forward 12-month price-to-earnings ratio for MSCI U.S. stood at 20.4, compared with 13.5 for MSCI Europe and 14.2 for MSCI Asia Pacific.
